The most significantly enriched drug was bepridil, which is a calcium antagonist known to affect mitochondrial function [19] that interacts with 4 genes with differential methylation in early-stage WD: ATP1A1, CACNA1H, TNNC1, and VIPR2 (p = 1.2E−4). This evidence concerns the gene ATP1A1 and Wilson disease.